Search research articles
Contact Us
Filters
Showing results (51-60 of 265) with videos related to
Page
of 27
Sort By:
Urology
|
October 11, 2003
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study
Darren J Little, Deborah A Kuban, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 25, 2003
Hazards of dose escalation in prostate cancer radiotherapy
Deborah Kuban, Alan Pollack, Eugene Huang, et al.
The Journal of Urology
|
February 10, 2004
Re: improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the search database
Mark K Buyyounouski, Eric M Horwitz, Alexandra L Hanlon, et al.
ACS Omega
|
December 20, 2021
Interactions of Urea-Based Inhibitors with Prostate-Specific Membrane Antigen for Boron Neutron Capture Therapy
Qiaoyu Hu, Kevin Padron, Daiki Hara, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy
Derek B Chism, Alexandra L Hanlon, Eric M Horwitz, et al.
JAMA
|
November 4, 2004
Androgen suppression plus radiation therapy for prostate cancer
Eric M Horwitz, Steven J Feigenberg, Alan Pollack, et al.
Oncotarget
|
March 10, 2016
An image guided small animal stereotactic radiotherapy system
Hao Sha, Thirupandiyur S Udayakumar, Perry B Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 10, 2003
Is intraoperative nomogram-based overplanning of prostate implants necessary?
Warren D D'Souza, Hoon K Lee, Matthew B Palmer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation
Mark K Buyyounouski, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2005
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement
Rojymon Jacob, Alexandra L Hanlon, Eric M Horwitz, et al.
Page
of 27
Search research articles
Search
Showing results (51-60 of 265) with videos related to
Sort By:
Page
of 27
Urology
|
October 11, 2003
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study
Darren J Little, Deborah A Kuban, Lawrence B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 25, 2003
Hazards of dose escalation in prostate cancer radiotherapy
Deborah Kuban, Alan Pollack, Eugene Huang, et al.
The Journal of Urology
|
February 10, 2004
Re: improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the search database
Mark K Buyyounouski, Eric M Horwitz, Alexandra L Hanlon, et al.
ACS Omega
|
December 20, 2021
Interactions of Urea-Based Inhibitors with Prostate-Specific Membrane Antigen for Boron Neutron Capture Therapy
Qiaoyu Hu, Kevin Padron, Daiki Hara, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 18, 2004
A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy
Derek B Chism, Alexandra L Hanlon, Eric M Horwitz, et al.
JAMA
|
November 4, 2004
Androgen suppression plus radiation therapy for prostate cancer
Eric M Horwitz, Steven J Feigenberg, Alan Pollack, et al.
Oncotarget
|
March 10, 2016
An image guided small animal stereotactic radiotherapy system
Hao Sha, Thirupandiyur S Udayakumar, Perry B Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 10, 2003
Is intraoperative nomogram-based overplanning of prostate implants necessary?
Warren D D'Souza, Hoon K Lee, Matthew B Palmer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 9, 2005
Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation
Mark K Buyyounouski, Alexandra L Hanlon, Eric M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 2005
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement
Rojymon Jacob, Alexandra L Hanlon, Eric M Horwitz, et al.
Page
of 27